CoChat

Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials

Majeed, Amna, Xiong, Jiaqi, Teopiz, Kayla M., Ng, Jason, Ho, Roger, Rosenblat, Joshua D., Phan, Lee, Cao, Bing, McIntyre, Roger S. · 2021 · Expert Opinion on Emerging Drugs
Cited by 48

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: The large percentage of adults with major depressive disorder (MDD) insufficiently responding and/or tolerating conventional monoamine-based antidepressants invites the need for mechanistically novel treatments. Convergent evidence implicates glutamatergic signaling as a potential therapeutic target in MDD. AREAS COVERED: The synthesis herein of preclinical and clinical studies indicates that dextromethorphan (DXM) is well tolerated and exhibits clinically significant antidepressant effects; DXM combined with bupropion has demonstrated replicated and relatively rapid onset efficacy in adults with MDD. DXM efficacy has been preliminarily reported in adults with bipolar depression. The combination of DXM and bupropion represents a pharmacokinetic and pharmacodynamic synergy which may account for the rapidity of action in MDD. EXPERT OPINION: The combination of DXM and bupropion is a safe, well tolerated and efficacious treatment option in adults with MDD. Priority questions are whether DXM/bupropion is uniquely effective across discrete domains of psychopathology (e.g. anhedonia, reward processing, general cognitive systems) and/or whether it is able to significantly improve patient-reported outcomes (e.g. quality of life, psychosocial functioning). The availability of ketamine/esketamine and DXM/bupropion instantiates the relevance of glutamate as a treatment target in MDD. Studies in bipolar depression with DXM/bupropion are warranted as well as in MDD with suicidality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14728214.2021.1898588

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 65

  1. GBD 2017, 2018, Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 · DOI · Paper page
  2. 10.1016/S0140-6736(20)30925-9 · DOI · Paper page
  3. 10.1016/j.psc.2018.04.001 · DOI · Paper page
  4. 10.1586/ern.09.137 · DOI · Paper page
  5. 10.1126/science.1260781 · DOI · Paper page
  6. 10.1002/hup.1005 · DOI · Paper page
  7. 10.3109/15622975.2013.765593 · DOI · Paper page
  8. 10.1016/S0014-2999(99)00800-6 · DOI
  9. 10.1093/ijnp/pyaa054 · DOI
  10. 10.4088/JCP.18r12475 · DOI
  11. 10.1016/j.pharmthera.2016.04.010 · DOI · Paper page
  12. 10.1016/j.jad.2014.05.050 · DOI
  13. 10.1097/WNR.0000000000000646 · DOI
  14. 10.1016/j.biopha.2016.11.073 · DOI
  15. 10.1016/j.pbb.2017.09.005 · DOI
  16. 10.1016/j.pbb.2020.173003 · DOI
  17. Mesripour A, 2019, Thai J Pharm Sci, 43
  18. 10.1007/s00221-015-4290-0 · DOI
  19. Ijomone OM, 2019, Basic Clin Neurosci, 10, 393
  20. 10.1016/S0006-3223(02)01405-1 · DOI · Paper page
  21. 10.1016/j.pbb.2006.06.005 · DOI · Paper page
  22. Can A, 2012, J Vis Exp, e3769
  23. 10.1016/S0278-5846(01)00324-4 · DOI · Paper page
  24. 10.1007/978-1-4939-8994-2_10 · DOI · Paper page
  25. 10.1002/9780470942390.mo150068 · DOI
  26. Lauterbach EC, 2016, Psychopharmacol Bull, 46, 53
  27. Messias E, 2012, Prim Care Companion CNS Disord, 14
  28. 10.1186/s40345-019-0174-8 · DOI
  29. 10.1016/j.euroneuro.2019.09.585 · DOI
  30. 10.1097/JCP.0000000000000633 · DOI
  31. 10.1016/j.euroneuro.2020.09.249 · doi:10.1016/j.euroneuro.2020.09.249
  32. 10.1016/S0140-6736(20)31544-0 · DOI · Paper page
  33. 10.1016/j.euroneuro.2014.09.001 · DOI
  34. 10.1007/s12264-010-0323-7 · DOI · Paper page
  35. 10.1007/s002130051131 · DOI
  36. 10.1016/j.neubiorev.2005.03.017 · DOI · Paper page
  37. Martinak B, 2017, Psychopharmacol Bull, 47, 59
  38. 10.1097/WNF.0000000000000403 · DOI
  39. 10.1080/00207454.2018.1545771 · DOI
  40. 10.1016/j.bbi.2019.04.035 · DOI
  41. 10.1016/j.bbi.2019.04.032 · DOI · Paper page
  42. 10.1111/j.1742-7843.2009.00516.x · DOI · Paper page
  43. 10.1038/sj.mp.4001118 · DOI
  44. 10.4088/JCP.15com09904 · DOI
  45. 10.1523/JNEUROSCI.18-07-02697.1998 · DOI · Paper page
  46. 10.1034/j.1399-5618.2001.30604.x · DOI · Paper page
  47. 10.1016/j.pharmthera.2010.04.003 · DOI · Paper page
  48. 10.1097/00008877-200211000-00003 · DOI · Paper page
  49. 10.1016/j.euroneuro.2007.02.007 · DOI
  50. 10.1017/S1461145708008547 · DOI · Paper page
  51. 10.1016/j.bbr.2008.11.036 · DOI · Paper page
  52. 10.1016/j.neuint.2007.01.008 · DOI
  53. 10.1038/sj.bjp.0705998 · DOI · Paper page
  54. 10.1016/j.neuint.2011.07.013 · DOI
  55. 10.1007/s00213-013-3153-2 · DOI · Paper page
  56. 10.1016/j.mehy.2012.02.012 · DOI
  57. 10.1016/j.pneurobio.2015.12.001 · DOI · Paper page
  58. 10.1016/j.pnpbp.2015.02.015 · DOI
  59. 10.1016/0006-8993(94)90771-4 · DOI
  60. 10.1016/S0165-0173(00)00018-7 · DOI · Paper page
  61. 10.1016/S0166-4328(02)00312-1 · DOI
  62. 10.1016/j.neulet.2015.12.006 · DOI
  63. Feighner JP, 1999, J Clin Psychiatry, 60, 4
  64. 10.4088/JCP.13097tx3c · DOI · Paper page
  65. 10.1111/ajad.13114 · DOI

Cited by

See all 48

Metadata

Authors
Majeed, A., Xiong, J., Teopiz, K. M., Ng, J., Ho, R., Rosenblat, J. D., Phan, L., Cao, B., & McIntyre, R. S.
Venue
Expert Opinion on Emerging Drugs
Published
2021-01-02
Volume
26
Issue
1
Pages
63-74
ISSN
  • 1472-8214 (ISSN-L)
  • 1744-7623
OpenAlex
W3134298422
Cited by
48
References
22
FWCI
1.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials. https://app.cochat.ai/papers/10.1080/14728214.2021.1898588
The paper
Majeed, A., Xiong, J., Teopiz, K. M., Ng, J., Ho, R., Rosenblat, J. D., Phan, L., Cao, B., & McIntyre, R. S. (2021). Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials. Expert Opinion on Emerging Drugs. https://doi.org/10.1080/14728214.2021.1898588

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.